The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
about
NPP4 is a procoagulant enzyme on the surface of vascular endotheliumGolgi localization and functional expression of human uridine diphosphataseAdenosine and hypoxia-inducible factor signaling in intestinal injury and recoveryThe role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolismPlatelet signaling: a complex interplay between inhibitory and activatory networksAbiotic stress responses in plants: roles of calmodulin-regulated proteinsMolecular Basis of Purinergic Signal Metabolism by Ectonucleotide Pyrophosphatase/Phosphodiesterases 4 and 1 and Implications in StrokeA yeast Golgi E-type ATPase with an unusual membrane topology.Molecular cloning and characterization of a novel mammalian endo-apyrase (LALP1)Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brainIncreased platelet sensitivity to ADP in mice lacking platelet-type 12-lipoxygenaseThe expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neuronsAaron J. Marcus: in pursuit of perfectionTriatoma infestans apyrases belong to the 5'-nucleotidase family.Molecular cloning of the chicken oviduct ecto-ATP-diphosphohydrolase.Cytomegalovirus infection increases the expression and activity of ecto-ATPase (CD39) and ecto-5'nucleotidase (CD73) on endothelial cells.The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.The creation of an antithrombotic surface by apyrase immobilizationThe cDNA cloning of human placental ecto-ATP diphosphohydrolases I and II.Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae.Cystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation.A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties.Expression of functional recombinant mosquito salivary apyrase: a potential therapeutic platelet aggregation inhibitor.Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats.Increased CD39 nucleotidase activity on microparticles from patients with idiopathic pulmonary arterial hypertension.P2 receptors: new potential players in atherosclerosisOverexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection.Platelet adhesion under flow.Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8.E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role.The GDA1_CD39 superfamily: NTPDases with diverse functions.Historical perspective and future directions in platelet research.Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemiaPlatelets, atherosclerosis and the endothelium: new therapeutic targets?Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemiaIn vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemiaCD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell deathFlow-dependent expression of ectonucleotide tri(di)phosphohydrolase-1 and suppression of atherosclerosis.
P2860
Q24299151-EA959336-E087-4729-8496-0D0BFABF0D31Q24309506-C453A271-335A-48FC-8BFE-AE7B388A7E89Q24620924-3C92279A-3C9E-4808-B446-587562BAEFE2Q24629291-29D4976A-7609-456F-B48B-ECE83B85A4A4Q26765384-567E4470-AD3E-451A-9A8F-07AB508D0984Q26777181-C3582407-7870-4313-9591-C37233D033DDQ27680880-74957F1C-1175-4A69-8A7D-F93B2E0C821FQ27937264-55DDF55C-14F0-4048-9E1C-016DF6BE359EQ28115265-835311DD-C96A-47F7-BD78-B3419B514418Q28192804-8B7B7E71-49E9-4B0B-830B-86BA8491327CQ28508965-107142CC-F593-43B7-BFAF-D2BF94355A7EQ28575419-A527FA69-76D9-4DB8-9CBA-B9CAFD2B7880Q30357257-E794B8FB-9FA0-4D60-A1AF-016B9981A4ECQ31050837-5EA073D1-AF42-4C73-A147-0ED5D3C5B76AQ32060630-5F0407F2-8CC3-4881-81AB-509D947EE01BQ32065150-8A729910-4D05-4CAE-9029-02AC1BB6A278Q33381441-349858DF-D8DE-4581-B6F6-1EDE4734D05CQ33781557-D8651EA4-71EF-4040-80C1-C62A9FC9D568Q33867954-E388D4D6-F5F5-4ED5-8EA4-1C3DD502F871Q33886662-CE9C937F-A88D-4C6C-853B-B201D1899AC2Q33916983-2AE88A6D-F0AE-4323-8424-2CD9C1EAE676Q33917557-AB18AA7C-C8F1-4F93-8937-785030804BEEQ33985800-78E53719-2B85-4003-B460-BEFF977E9156Q33995865-95CE3650-D900-4029-9053-0BC9839D6B5FQ34020021-671854AB-D90F-4152-B644-402CCDCF56B8Q34336698-5EC9EE97-F06F-4639-976C-314D9D0DB812Q34542194-11B4EFD8-8877-4E59-8F04-46FBFAD2C15BQ34542781-240F8123-A20D-4392-802E-333FA190D32DQ34673739-144CB1DD-C88D-41EE-A232-96C6497F4B0EQ34769242-97581591-F091-468F-A25D-698F4040E050Q34847699-2EAF5AA9-1569-4617-B176-C3D8EE019BEFQ34868468-82795D84-D015-4BD6-A165-EC66227347F0Q35185593-003D9FB4-B4C8-4E8A-B0A1-2A782DEE268CQ35193886-68471974-0D86-4404-8C6C-3033E3DA51E0Q35570940-BAEBC58C-7CE6-4E6E-AA8D-988E67D9401AQ35574518-99376763-3CE4-4323-84D4-D4E65BFF17F3Q35779631-A21D4028-D63F-49E9-B13D-CD53C290DDA7Q35828073-2F3BFA36-B999-4ACF-835E-227BCB77998BQ35930211-840DA7A0-4C76-4D3A-9597-24A4C7EEE9D2Q36040470-869EA41D-8DE3-4BA6-913E-7B9C175A50AA
P2860
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
@ast
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
@en
type
label
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
@ast
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
@en
prefLabel
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
@ast
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
@en
P2093
P2860
P356
P1476
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
@en
P2093
A J Marcus
C R Maliszewski
D N Posnett
J H Drosopoulos
K A Hajjar
K A Schooley
L B Safier
M A Schoenborn
M J Broekman
P2860
P304
P356
10.1172/JCI119294
P407
P577
1997-03-01T00:00:00Z